Posts Tagged
Pharmaceutical and biotechnology stocks may gain if the expected stalemate in Congress takes the threat of drug pricing restrictions off the table
Market Guide to the Midterms: What Goldman, SocGen Are Watching
published Nov 6, 2018, 3:33:52 PM, by Joanna Ossinger and Felice Maranz (Bloomberg) — The U.S. midterm elections are upon us, and the results will have implications for everything from bond yields to equity volatility. Here’s a sampling of what strategists are saying about the outlook for markets. Taxes and
